Phase 2 Allergies Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Chronic Obstructive Pulmonary Disease (COPD)Allergies
Johns Hopkins University334 enrolled23 locationsNCT07059091
Recruiting
Phase 2
Omalizumab Weight-Based Dosing Efficacy Trial
Allergies
Massachusetts General Hospital30 enrolled3 locationsNCT06943534